Compounding of Veterinary Drugs for Equine Practitioners

被引：1
|
作者：
Stanley, Scott D. [1 ]
Moffitt, Krysta [1 ]
Wiebe, Valerie [2 ,3 ]
机构：
[1] Univ Calif Davis, Sch Vet Med, KL Maddy Equine Analyt Chem Lab, 620 West Hlth Sci Dr, Davis, CA 95616 USA
[2] Univ Calif Davis, Pharm, William R Prichard Vet Med Teaching Hosp, Davis, CA 95616 USA
[3] Univ Calif Davis, Dept Med & Epidemiol, William R Prichard Vet Med Teaching Hosp, Davis, CA 95616 USA
来源：
VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE | 2017年 / 33卷 / 01期
关键词：
Compounding; Extralabel drug use; Drugs; Horses; INFECTIONS; PHARMACY; OUTBREAK;
D O I：
10.1016/j.cveq.2016.12.003
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence based medicine; (2) compliance with the Animal Medicinal Drug. Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.
引用
收藏
页码：213 / +
页数：14
相关论文
共 50 条
12345